Aleen Inc. Advances Development of Smart Analytics Feature
Toronto, ON — December 02, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, continues its structured path from early exploration and user testing to personal account development, and now moves into full-scale creation of its Smart Analytics feature....
Doseology Announces Launch of Corporate Communications Program
Kelowna, BC – December 1, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand...
BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
VANCOUVER, BC, November 19, 2025 - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has closed its previously announced non-brokered private placement financing (the “Offering”) of 11,311,676 units of the Company (the...
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
LAS VEGAS, NEVADA, November 18, 2025 - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...
Aleen Inc. Identifies Core Insights from Concept Testing Phase
Toronto, ON — November 18, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announced the completion of its initial concept testing for the upcoming Smart Analytics feature. The research provided valuable insight into how users interact with wellness tools...
Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance
Vancouver, British Columbia – November 17, 2025 – Scope Technologies Corp. (CSE: SCPE | OTC: SCPCF | FSE: VN8) (“Scope Technologies” or the “Company”) is pleased to announce that it has successfully achieved Level 2 Certification under the CyberSecure Canada program...
BioVaxys Technology Corp. Announces Debt Settlement Transaction
VANCOUVER, BC, November 13, 2025 - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has entered into debt settlement agreements with certain creditors of the Company (the “Creditors”) pursuant to which the Company has...
QSE Group – a Scope Technologies Division Collaborates with Enzo Plus to Accelerate Quantum Security Adoption Across Southeast Asia
Vancouver, British Columbia – November 13, 2025 – Scope Technologies Corp. (CSE: SCPE | OTC: SCPCF | FSE: VN8) (“Scope Technologies”, “QSE” or the “Company”) is pleased to announce that its QSE Group division has signed a...
Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.
Doseology USA Inc. Kelowna, BC – November 13, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that its wholly owned Florida subsidiary,...
BIOVAXYS ANNOUNCES EXTENSION OF LIFE OFFERING CLOSING DATE
BIOVAXYS ANNOUNCES EXTENSION OF LIFE OFFERING CLOSING DATE // NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, November 11, 2025 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the...
Exchange News
Regulatory News
Media Relations
Public Relations
Disclosure Services